Posts

Good information about the growing importance of Social Collaboration
http://thehealthcareblog.com/…/healthcare-ceos-weigh-in-on…/

Technology is transforming health care in many ways. CEOs of health care businesses think the biggest transformation in the next few years will come from making patients, doctors and health-care workers more communicative and collaborative.
thehealthcareblog.com

Interesting article about patient access to doctors notes and physicians use of social networking.
Health in Your Hands http://t.co/4O968D6A

If one thing is trending right now in the healthcare arena it's putting health care where it belongs: right back into the consumer's hands. Makes a lot of sense, right? Patient-centered care vs. institutionalized care. Health-care vs. disease-care. For some, that means having online access to their
zite.to
Posts

Consumer use of mobile devices for healthcare continues to grow http://t.co/bcZmL85l

The number of U.S. consumers ages 18 or older taking advantage of mobile resources for healthcare purposes continues to rise, according to New York City-based Manhattan Research.
fiercemobilehealthcare.com

A look into a researchers journey with Diabetes and the implications of his study on personalized medicine.

http://www.nytimes.com/…/geneticists-research-finds-his-own…

The benefits of human genome sequencing may be enhanced with detailed blood tests — as found in a case study involving a geneticist’s own Type 2 diabetes.
nytimes.com

Patients dealing with chronic disease are taking matters inot their own hands.

http://online.wsj.com/…/SB100014240527023048184045773459539…

Some patients with fatal Lou Gehrig's disease are trying to brew their own version of an experimental compound at home and testing it on themselves.
online.wsj.com

How the effective implementation of n of 1 studies can provide valuable data on chronic disease.

http://www.lybba.org/…/c3n-helps-patients-take-health-into…/

On Inspire.com, a woman discusses her quest to remedy her own symptoms of psoriasis. “In my search for a livable solution to my very severe psoriasis,” she says, “I have begun searching for ‘cause and effect’ instead of the ever more popular ‘symptom treatment&rsq...
lybba.org

Interesting article on the challenges that Pharmaceutical companies are having leveraging social media to interact with patients.

http://www.pharma-iq.com/…/opportunities-and-risks-social…/…

Opportunities and Risks: Social Media Activities and Pharmacovigilance Responsibilities by Pharma IQ - On Monday Facebook stopped letting pharmaceutical companies disable the comments feature on their company pages. This change has prompted some pharmaceutical companies, such as AstraZenec
pharma-iq.com

This article points to the need for a different way of approaching clinical trial design.
http://www.pharma-iq.com/…/the-importance-of-innovation-i…/…

The Importance of Innovation in Trial Design by Pharma IQ - Clinical development is expensive, invariably high risk and at times enormously inefficient, which is most likely the reason why productivity is sliding so rapidly in the pharmaceutical industry. W
pharma-iq.com
N=you
March 2011

N-of-1 studies are an effective tool in clinical trial design

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118090/

N-of-1 or single subject clinical trials consider an individual patient as the sole unit of observation in a study investigating the efficacy or side-effect profiles of different interventions. The ultimate goal of an n-of-1 trial is to determine the optimal or best intervention for an individual pa...
ncbi.nlm.nih.gov

This is a very interesting article about the how an associate professor of dermatology and genetics at Columbia University Medical Center changed the course of research in her area because of having the condition herself
http://www.nytimes.com/2010/…/28/science/28conversation.html

A bout with alopecia 15 years ago led Dr. Christiano to study the hair loss disease.
nytimes.com